A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect

Abstract

As a result of the deficient tumor‐specific antigens, potential off‐target effect, and influence of protein corona, metal–organic framework nanoparticles have inadequate accumulation in tumor tissues, limiting their therapeutic effects. In this work, a pH‐responsive linker (L) is prepared by covalently modifying oleylamine (OA) with 3‐(bromomethyl)‐4‐methyl‐2,5‐furandione (MMfu) and poly(ethylene glycol) (PEG). Then, the L is embedded into a solid lipid nanoshell to coat apilimod (Ap)‐loaded zeolitic imidazolate framework (Ap‐ZIF) to form Ap‐ZIF@SLN#L. Under the tumor microenvironment, the hydrophilic PEG and MMfu are removed, exposing the hydrophobic OA on Ap‐ZIF@SLN#L, increasing their uptake in cancer cells and accumulation in the tumor. The ZIF@SLN#L nanoparticle induces reactive oxygen species (ROS). Ap released from Ap‐ZIF@SLN#L significantly promotes intracellular ROS and lactate dehydrogenase generation. Ap‐ZIF@SLN#L inhibits tumor growth, increases the survival rate in mice, activates the tumor microenvironment, and improves the infiltration of macrophages and T cells in the tumor, as demonstrated in two different tumor‐bearing mice after injections with Ap‐ZIF@SLN#TL. Furthermore, mice show normal tissue structure of the main organs and the normal serum level in alanine aminotransferase and aspartate aminotransferase after treatment with the nanoparticles. Overall, this pH‐responsive targeting strategy improves nanoparticle accumulation in tumors with enhanced therapeutic effects.

Pt(IV) prodrug initiated microparticles from microfluidics for tumor chemo-, photothermal and photodynamic combination therapy

“…Microfluidic technology with high precision and controllability has been widely used to prepare multifunctional microparticles or microcapsules for various biomedical applications including drug/cell delivery, cell culture, and tissue engineering [ [27] , [28] , [29] , [30] , [31] , [32] ]. Especially, the resultant microparticles or microcapsules with tunable sizes, dispersity, structures, and components could be employed as delivery systems of multimodal tumor therapy [ [33] , [34] , [35] , [36] ]. Although with many successes, the generation of most of these polymer microcarriers often requires additional extra initiators.…”

Enzyme-catalyzed synthesis of selenium-doped manganese phosphate for synergistic therapy of drug-resistant colorectal cancer

“…3 and 5 . Furthermore, both in vitro and in vivo studies demonstrated that OX@Se-MnP NPs are taken up by colorectal cancer cells and continue to generate ·OH via a Fenton-like catalytic reaction, subsequently triggering caspase-mediated tumor apoptosis[ 62 ]. Thus, Se-MnP NPs function synergistically with OX to induce apoptosis in vitro and suppress tumor growth in vivo.…”

Microfluidic Synthesis of the Tumor Microenvironment-Responsive Nanosystem for Type-I Photodynamic Therapy

“…Microfluidic technology, as one of the most promising technologies, can well integrate the nanoparticle synthesis platform into a small glass chip, rendering the synthesis of nanoparticles more controllable [ 26 ]. In general, the small size of nanoparticles, their large specific surface area, and their quantum size effect endow them with special properties lacking in conventional materials [ 27 ].…”